BSECompany Update3 Nov 2026 · 3 Nov 2026, 03:35 pm
Audio recording of Earning/ Quarterly Conference Call
Akums Drugs and Pharmaceuticals Ltd · 544222
✦ AI SummaryResults
Akums Drugs and Pharmaceuticals Ltd has announced the audio recording of its quarterly conference call for the un-audited financial results for the quarter and half year ended on September 30, 2026. The link to the audio recording is provided, and the transcript will be shared with stock exchanges and uploaded on the company's website.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Akums Drugs and Pharmaceuticals Ltd - 544222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
69453ee3-6679-4ebe-a137-fdbad487c405.pdf
View document text
Ref: Akums/Exchange/2026-27/63 November 03, 2026
To, To,
The Listing Department The Listing Department
National Stock Exchange of India Ltd. BSE Limited
Exchange Plaza, C-1, Block G, 25th Floor, New Trading Ring,
Bandra Kurla Complex, Rotunda Building, Phiroze Jeejeebhoy
Bandra (E), Mumbai – 400 051 Towers, Dalal Street, Mumbai – 400 001
Symbol: AKUMS Scrip Code: 544222
Sub: Audio recording of Earning/ Quarterly Conference Call held on the un-audited
financial results for the quarter and half year ended on September 30, 2026
Respected Sir/Ma’am,
Pursuant to the Regulation 30 read with Part A of Schedule III of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please
find below the link of audio recording of Earning/ Quarterly Conference Call held today i.e.
Tuesday, November 03, 2026 at 12:00 PM (IST) on the un-audited financial results of Akums
Drugs and Pharmaceuticals Limited (“the Company”) for the quarter and half year ended
on September 30, 2026.
Link: https://www.akums.in/wp-content/uploads/2026/11/Q2-FY27-Audio-Recording.mp3
The transcript for the said call will be shared with the Stock Exchanges and will also be
uploaded on the Company’s website at https://www.akums.in/investors/investors-meet/
in due course.
This is for your kind information and record.
Thanking You
Yours Faithfully
For Akums Drugs and Pharmaceuticals Limited
Dharamvir Malik
Company Secretary & Compliance Officer